A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second -line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA) Meeting Abstract


Authors: Greally, M.; Jha, S.; Yoon, S. S.; Li, J.; Desai, A. M.; Won, E.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Aljallad, K.; Ku, G. Y.
Abstract Title: A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second -line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)
Meeting Title: 2019 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 4 Suppl.
Meeting Dates: 2019 Jan 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000489107600162
DOI: 10.1200/JCO.2019.37.4_suppl.116
PROVIDER: wos
Notes: Meeting Abstract: 116 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sam Yoon
    108 Yoon
  2. Geoffrey Yuyat Ku
    230 Ku
  3. Yelena Yuriy Janjigian
    394 Janjigian
  4. David H Ilson
    433 Ilson
  5. David P Kelsen
    537 Kelsen
  6. Elizabeth Siryeon Won
    41 Won
  7. Avni Mukund Desai
    20 Desai
  8. Jia Li
    17 Li
  9. Megan Greally
    30 Greally